Accent Microcell logo

Accent Microcell financials and balance sheet

NSE: ACCENTMICChemicals & Petrochemicals

Last close ₹592.50down ₹24.15 (3.92%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹616.65.

52-week range of traded prices to 23 Oct 2026
₹253.00Low, 30 Oct 2025₹731.70High, 15 Sep 2026
Market cap
₹1,421 Cr
P/E
25.0
P/B
4.7
Dividend yield
0.17%
ROE
20.5%
Debt to equity
0.00
Volume, NSE
73,50062.6% delivered

3 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Accent Microcell annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹349 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue349
  2. Materials and goods−216
  3. Employee costs−18
  4. Other expenses−58
  5. Operating profit57
  6. Depreciation−4.7
  7. Other income+6.8
  8. Finance costs−0.5
  9. Profit before tax58
  10. Tax−14
  11. Net profit44

What the company owns

  • Plant, investments and other assets₹178 Cr
  • Receivables₹91 Cr
  • Inventory₹32 Cr
  • Cash and bank₹20 Cr

What pays for it: net worth and liabilities

  • Net worth₹275 Cr
  • Other liabilities₹26 Cr
  • Owed to suppliers₹20 Cr
  • Borrowings₹1 Cr

Accent Microcell business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Standalone, ₹ crore, as the company reports them.Accent Microcell segment results by half year

Revenue by segment

₹386 CrTotal
  • Dahej (SEZ Unit)₹231 Cr59.9% of total
  • Pirana₹153 Cr39.7% of total
  • C Unit-III₹2 Cr0.4% of total

Profit by segment

  • Dahej (SEZ Unit)₹52.7 Cr89.7% of total
  • Pirana₹4.9 Cr8.3% of total
  • C Unit-III₹1.2 Cr2.0% of total

Segment results by year

Standalone, ₹ crore, years to March.

  • Dahej (SEZ Unit)

    Revenue, ₹ crore
    Profit, ₹ crore
  • Pirana

    Revenue, ₹ crore
    Profit, ₹ crore
  • C Unit-III

    Revenue, ₹ crore
    Profit, ₹ crore
  • d Inter Unit Sales

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2025Mar 2026
Revenue of all businesses279386
Company revenue, as in its results265349
Revenue152231
Revenue growth–52.4%
Profit3853
Profit growth–38.6%
Margin25.1%22.8%
Return on capital76.6%88.1%
Assets6885
Liabilities1825
Capital employed5060
Revenue123153
Revenue42
Revenue–−30
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Standalone, ₹ crore, years to March.Accent Microcell half-yearly results

₹ croreMar 2024Mar 2025Filed 12 MayMar 2026Filed 12 May
Revenue from operations245265349
206223292
Materials and goods bought146162216
Employee costs111518
Other expenses494658
Operating profit before depreciation394257
Operating margin16.1%15.8%16.2%
Materials, % of revenue59.4%61.0%61.9%
Employee costs, % of revenue4.5%5.9%5.2%
Other expenses, % of revenue20.0%17.3%16.6%
Depreciation and amortisation445
Operating profit after depreciation353852
Other income467
Finance costs101
Profit before one-off items and tax384458
One-off items−1––
Profit before tax374458
61114
Net profit303344
Net margin12.3%12.5%12.6%

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2025Filed 12 MayMar 2026Filed 12 MaySep 2026Half yearFiled 14 Oct
195275304
Share capital212424
Reserves174251280
211
304438
333
Total assets228322346
74167218
154155127
Net debt−50−19−17
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2025Filed 12 MayMar 2026Filed 12 MaySep 2026Half year
24.718.678.3
36.032.291.9
−8.5−30.548.4
Receivables−11.2−25.346.5
Inventories−0.61.2−2.9
Payables−0.61.23.4
Other working capital3.9−7.61.4
Tax paid−10.9−12.9−13.6
Capital spending36.887.761.3
Free cash flow−12.2−69.017.0
−8.6−48.9−84.6
−13.735.7−2.7
Dividends paid2.12.42.4
Shares issued0.039.20.0
Net change in cash2.45.5−9.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the year to Mar 2024.

Per share

Standalone, ₹ per share, years to March.Accent Microcell dividend history

₹ per shareMar 2024Mar 2025Filed 12 MayMar 2026Filed 12 May
Earnings per share–₹15.71₹18.65
Diluted earnings per share–₹15.71₹18.65
Dividend per share₹1.00₹1.00₹1.00
Book value per share–₹92.57₹114.84
Dividend payout7.0%6.4%5.5%
Shareholder yield–0.5%−4.3%
Market cap at the year end (₹ crore)517402852

Ratios

Standalone, years to March.Accent Microcell PE ratio and valuation

RatioMar 2024Mar 2025Filed 12 MayMar 2026Filed 12 May
Revenue growth–7.8%31.9%
Operating profit growth–6.2%35.3%
Net profit growth–9.6%32.7%
Earnings per share growth––18.7%
–17.0%18.7%
––1.7 pts
From the net margin––0.1 pts
From asset turnover––1.6 pts
From borrowing––0.0 pts
Return on capital employed–19.2%18.8%
Cash conversion–74.6%42.5%
Interest cover30.6109.196.3
Debt to equity–0.010.00
Receivable days–9095
Inventory days–7655
Payable days–4233
Cash conversion cycle, days–124117
Working capital days–10296
Asset turnover–1.161.27
Assets per rupee of net worth–1.171.17
Sales per rupee of plant–5.516.58
Capital spending to depreciation–8.7418.82
No balance sheet is on record for the year to Mar 2024, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
15.9%
Cash from operations against operating profit
32.9%
Measure3 years
Return on equity, average17.8%
Return on capital employed, average19.0%
Operating margin, average16.1%
Net margin, average12.5%
Asset turnover, average1.21
Cash conversion cycle, days, average120
Interest cover, average78.7
Debt to equity, average0.01

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ croreLatest year
Cash from operations18.6
Cash from investing−48.9
Cash from financing35.7
Capital spending87.7
Dividends paid2.4
Shares issued for cash39.2
Borrowings raised0.0
Borrowings repaid0.6

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2024Mar 2025Mar 2026
Receivables growth less revenue growthOur threshold 0 percentage points––8.81
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––−37.40
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––1.80
Effective tax ratePublished threshold 17.16 per cent17.4124.4424.72
Tax charged less tax paid, % of profitOur threshold 10 percentage points–−0.452.52
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
22 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesLong-term scaleCrisil BB-(Issuer Not Cooperating)Rating RevisedStable9.25
22 Oct 2026CRISIL Ratings Limited (opens in a new tab)Bank FacilitiesShort-term scaleCrisil A4+(Issuer Not Cooperating)Rating Revised7
25 Mar 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - LT/ ST-Bank GuaranteeLong and short-term scalesWithdrawnWithdrawn
25 Mar 2026CARE Ratings Limited (opens in a new tab)Fund-based - ST-Bill Discounting/ Bills PurchasingShort-term scaleCARE A2+Review, Upgrade2
25 Mar 2026CARE Ratings Limited (opens in a new tab)LT/ST Fund-based/Non-fund-based-EPC / PCFC / FBP / FBD / WCDL / OD / BG / SBLCLong and short-term scalesCARE A- / CARE A2+Review, UpgradeStable35
25 Mar 2026CARE Ratings Limited (opens in a new tab)Fund-based - LT-Term LoanLong-term scaleCARE A-Review, UpgradeStable1.48
25 Mar 2026CARE Ratings Limited (opens in a new tab)Fund-based - ST-Forward ContractShort-term scaleCARE A2+Review, Upgrade3.50
25 Mar 2026CARE Ratings Limited (opens in a new tab)Non-fund-based - ST-Letter of creditShort-term scaleWithdrawnWithdrawn
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.